XXXX Surveillance: Are We Utilizing It?

@entity1 @entity157 @entity82
BACKGROUND AND GOALS: International guidelines recommend 6-monthly ultrasound scan surveillance in cirrhotic @entity1 for @entity157 ( @entity157 ) screening. The aim of this study was to evaluate @entity157 surveillance and to provide the outcomes for the largest reported @entity82 cohort in the United Kingdom. STUDY: We retrospectively reviewed all cirrhotic @entity1 during the 6 months before April 1, 2014 at 3 teaching hospitals within the Imperial College Healthcare NHS Trust. All @entity1 with @entity82 eligible for @entity157 screening in the cohort were reviewed for evidence of screening and were characterized as either "routine" or "overdue." Reasons for failure to meet guidelines were identified in overdue @entity1 . Univariate analyses were conducted to determine clinical and sociodemographic predictors of surveillance with a view to performing multivariate analysis. RESULTS: Of the 898 @entity1 eligible for inclusion, 65% @entity1 had @entity157 surveillance performed in the past 6 months. During the observation period, 61 (6.8%) cases of @entity157 were detected. Thirty-eight were picked up on surveillance, 9 incidentally and in 14 cases it could not be determined from the notes. Within this cohort HCCs diagnosed on surveillance did not demonstrate significantly superior outcomes compared with those picked up incidentally. CONCLUSIONS: Surveillance of @entity1 with @entity82 within this cohort is suboptimal. Although disappointing at a local level, this is likely to be reflective of practice elsewhere.
